Ganacan, Jorry L.
HRN: 27-05-06 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/28/2025
CEFTRIAXONE 1G (VIAL)
04/28/2025
05/05/2025
IV
2g
Q 24H
Multiple Stab Wounds, Posterior Thorax; S/P Wound Suturing
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes